Microfluidic Droplet Platform for Single-Cell NK Cell Heterogeneity Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack the capability to dynamically and effectively analyze the heterogeneity of natural killer (NK) cell responses, particularly in the presence of PD-L1 inhibitors, which is crucial for optimizing immunotherapy and understanding cancer immunology.
Innovation Solution
A microfluidic droplet-based platform that co-encapsulates NK cells and tumor cells, allowing for real-time analysis of cell-cell interactions, cytotoxicity, and the impact of PD-L1 inhibitors, using an agent-based model to simulate disease states and predict treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to analyze NK cell responses, then the analysis is simpler, but the capability to dynamically and effectively analyze heterogeneity is insufficient
Solution Approach 1:
The patent segments the analysis by isolating individual NK cells and target cells in separate microdroplets, enabling single-cell resolution analysis. This segmentation allows dynamic monitoring of heterogeneity in NK cell responses without the averaging effect of bulk methods, directly improving measurement precision while using a microfluidic platform to manage the complexity.
Solution Approach 2:
The patent introduces microdroplets as an intermediary medium to encapsulate and isolate cell pairs. This intermediary enables controlled interaction environments, facilitates real-time monitoring, and allows the integration of multiple analysis functions (optical, electrical, magnetic) within a manageable platform architecture.
2Productivity
If microfluidic droplet-based platform is used, then real-time analysis of cell-cell interactions is enabled, but the device complexity increases
Solution Approach 1:
The microfluidic droplet platform is designed to perform multiple functions: cell encapsulation, interaction monitoring, cytotoxicity detection, and data acquisition. By integrating these functions into a single universal platform, the system achieves real-time analysis capability while avoiding the need for multiple separate complex devices.
Solution Approach 2:
The microdroplets self-assemble and automatically isolate cell pairs, creating controlled interaction environments without manual intervention. This self-service capability reduces operational complexity and enables high-throughput real-time analysis of multiple cell interactions simultaneously.
3Measurement precision
If single-cell level analysis is performed, then cellular heterogeneity is revealed, but the time resolution for dynamic events is reduced
Solution Approach 1:
The patent implements continuous monitoring of encapsulated cell pairs using real-time detection methods (optical, electrical, or magnetic sensors). This continuous action maintains both single-cell resolution for heterogeneity detection and high temporal resolution for capturing dynamic events such as synapse formation and cytotoxicity progression.
Data Source
AI summary
Bioassays are provided for detecting and analyzing responses from single cells and cell pairs suspended in micro-scale droplets (80-200 μm diameter) generated in microfluidic devices. Cell responses to various stimuli are analyzed. The stimuli are delivered by homotypic or heterotypic cells, small molecule drugs, and therapeutic agents including immunotherapeutics. The bioassays can be used to describe heterogeneity in any given cell population, and can be used in a clinical setting, such as profiling of patient-derived cells, designing personalized treatment strategies, and optimizing drug combinations for immunotherapy of tumors.